🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To investigate the pharmacokinetics of a single 900 mg oral dose of BIA 2-0...
Status
Completed
Location
BIAL - Portela & Cª - Human Pharmacology Unit (UFH)
Start Date
2002-03
Trial ID
NCT01678976
Treatments Being Tested
A pediatric drug study to determine the long-term safety and tolerability i...
Status
Withdrawn
Location
Child Neurology Specialists / Clinical Research Center of Nevada, LLC
Start Date
2017-07-06
Trial ID
NCT03108729
Treatments Being Tested
A randomized, double-blind, placebo-controlled and open label active-contro...
Status
Completed
Location
Comprehensive Phase OneTM
Start Date
2007-03
Trial ID
NCT02283788
Treatments Being Tested
Single centre, open-label, multiple doses, one-sequence design study in two...
Status
Completed
Location
Multiple Locations
Start Date
2007-01
Trial ID
NCT02283814
The primary objective of this study is to assess the efficacy of Eslicarbaz...
Status
Terminated
Location
Synexus ClinPharm GmbH
Start Date
2010-09
Trial ID
NCT01124097
Treatments Being Tested
The primary objective of the study is to assess the efficacy of eslicarbaze...
Status
Completed
Location
Multiple Locations
Start Date
2007-11
Trial ID
NCT00980746
Treatments Being Tested
This is a multicenter, non-interventional, prospective study. The observati...
Status
Completed
Location
Hospital Fernando da Fonseca
Start Date
2012-03
Trial ID
NCT01532726
Treatments Being Tested
This is a long term, open-label, safety extension study in subjects with pa...
Status
Completed
Location
Neurology Clinic, P.C.
Start Date
2009-08
Trial ID
NCT00910247
Treatments Being Tested
The purpose of this research study is to determine if the blood tests used ...
Status
Completed
Location
The More foundation/The Core Institute
Start Date
2015-09
Trial ID
NCT02491073
Treatments Being Tested
Single centre, double-blind, randomised, placebo-controlled study of two do...
Status
Completed
Location
Human Pharmacology Unit - BIAL - Portela & Ca, S.A.
Start Date
2004-10
Trial ID
NCT01879345
Treatments Being Tested